Shimadzu offers a total solution to researchers working within pharmaceutical industries. Our integrated workflows give them accurate and comprehensive data, resulting in the efficient discovery of targets and biomarkers, and rapid selection and validation of drug candidates. We provide unique tools novel systems for the analysis of nucleic acids, proteins, peptides and saccharides.
From direct DNA amplification using a drop of blood (Ampdirect plus) to automated DNA/RNA fragment analysis (MultiNA), our reagents and instruments offer a comprehensive solution to genomics research.
Disease and/or phenotype specific proteins are important
targets in basic pharmaceutical research. Gel-separated
proteins or chromatographically resolved peptides can be
characterized and identified by high throughput
MALDI TOF Mass Spectrometry using the Shimadzu AXIMA
series.
These MALDI mass spectrometers can also serve as robust
detection systems using off-line LC-MALDI. Stable isotope
labeling (with 13CNBS reagent), nanoLC (Prominence nano)
and the LC-MALDI coupling (AccuSpot) enable comparative
proteome analyses and biomarker discovery experiments.

Glycosylation is a key post-translational modification associated with the function of many proteins. By using the unique hybrid MALDI-TOF MS AXIMA-QIT, detailed structure of the glycan and the site of post translational modification can be determined.
The combination of accurate and sensitive MSn analysis with the LCMS-IT-TOF mass spectrometer and the Profiling Solution statistical analysis tool make it possible to mine metabolic markers from highly complex biological samples.
MALDI-MS Imaging allows researchers to analyze the spatial
distribution of target molecules in tissue samples. Proteins,
lipids and even drugs and their metabolites can be analyzed
directly from tissues.
The combination of chemical inkjet printing (CHIP-1000) and
high sensitivity MSn analysis (AXIMA-QIT) allow protein,
peptide and drug distributions to be determined from classical
histological tissue samples. Also, a unique hybrid MALDI-MS
microscope is under development, enabling researchers to
combine optical microscopy with sensitive and accurate
MALDI-MS.
Clairvivo PET is used for in vivo molecular imaging.
disease staging and monitoring. Small animal PET imaging is
also being used to study gene expression, drug uptake and
brain function.
The scanning probe microscope SPM-9600 allows biomolecules such as DNA and proteins to be directly observed without any sample coating or pretreatment. For example, it can be applied to DNA/protein interaction imaging.
